Philip S. Schein is Director at MEDICIS PHARMACEUTICAL CORP (MRX). They have made 1 open-market trade across 1 company since 2010, most recently 2012-12-11.
CIK 0001257561
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRX | 8,222 | $579K |
Shares reported on the most recent Form 4, priced at the 2012-05-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRX | SELL | 2010-11-29 | 2010-11-30 | $26.30 | $855K | +2.8% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.